CO6870037A2 - Fenil-3-aza-biciclo[3,1,0]hex-3-il-metanonas y su uso como medicamento - Google Patents

Fenil-3-aza-biciclo[3,1,0]hex-3-il-metanonas y su uso como medicamento

Info

Publication number
CO6870037A2
CO6870037A2 CO14022058A CO14022058A CO6870037A2 CO 6870037 A2 CO6870037 A2 CO 6870037A2 CO 14022058 A CO14022058 A CO 14022058A CO 14022058 A CO14022058 A CO 14022058A CO 6870037 A2 CO6870037 A2 CO 6870037A2
Authority
CO
Colombia
Prior art keywords
methanones
aza
bicyclo
hex
medicine
Prior art date
Application number
CO14022058A
Other languages
English (en)
Inventor
Riccardo Giovannini
Barbara Bertani
Marco Ferrara
Iain Lingard
Rocco Mazzaferro
Holger Rosenbrock
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of CO6870037A2 publication Critical patent/CO6870037A2/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
CO14022058A 2011-08-03 2014-02-03 Fenil-3-aza-biciclo[3,1,0]hex-3-il-metanonas y su uso como medicamento CO6870037A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11176468 2011-08-03

Publications (1)

Publication Number Publication Date
CO6870037A2 true CO6870037A2 (es) 2014-02-20

Family

ID=46598566

Family Applications (1)

Application Number Title Priority Date Filing Date
CO14022058A CO6870037A2 (es) 2011-08-03 2014-02-03 Fenil-3-aza-biciclo[3,1,0]hex-3-il-metanonas y su uso como medicamento

Country Status (37)

Country Link
US (1) US9012489B2 (es)
EP (1) EP2739615B1 (es)
JP (1) JP5850589B2 (es)
KR (1) KR101944686B1 (es)
CN (2) CN105837562B (es)
AP (1) AP2014007399A0 (es)
AR (1) AR087436A1 (es)
AU (1) AU2012292036C1 (es)
BR (1) BR112014001642B1 (es)
CA (1) CA2843805C (es)
CL (1) CL2014000246A1 (es)
CO (1) CO6870037A2 (es)
CY (1) CY1119326T1 (es)
DK (1) DK2739615T3 (es)
EA (1) EA024933B1 (es)
EC (1) ECSP14013221A (es)
ES (1) ES2623006T3 (es)
GE (1) GEP20166483B (es)
HK (1) HK1193100A1 (es)
HR (1) HRP20170695T1 (es)
HU (1) HUE033134T2 (es)
IL (1) IL229962A (es)
LT (1) LT2739615T (es)
MA (1) MA35286B1 (es)
ME (1) ME02672B (es)
MX (1) MX347828B (es)
MY (1) MY167396A (es)
PE (1) PE20141352A1 (es)
PL (1) PL2739615T3 (es)
PT (1) PT2739615T (es)
RS (1) RS55927B1 (es)
SI (1) SI2739615T1 (es)
TN (1) TN2014000044A1 (es)
TW (1) TWI543974B (es)
UA (1) UA114405C2 (es)
UY (1) UY34239A (es)
WO (1) WO2013017657A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106455572B (zh) 2014-06-06 2020-01-14 巴斯夫欧洲公司 取代噁二唑在防除植物病原性真菌中的用途
AR106679A1 (es) 2015-11-13 2018-02-07 Basf Se Oxadiazoles sustituidos para combatir hongos fitopatógenos
EP3373735A1 (en) 2015-11-13 2018-09-19 Basf Se Substituted oxadiazoles for combating phytopathogenic fungi
EA201891146A1 (ru) 2015-11-19 2018-12-28 Басф Се Замещенные оксадиазолы для борьбы с фитопатогенными грибами
AU2017250397A1 (en) 2016-04-11 2018-10-11 Basf Se Substituted oxadiazoles for combating phytopathogenic fungi
WO2018224455A1 (en) 2017-06-07 2018-12-13 Basf Se Substituted cyclopropyl derivatives
CN113784966A (zh) 2019-05-01 2021-12-10 勃林格殷格翰国际有限公司 Glyt1抑制剂的固体形式
WO2021142329A1 (en) 2020-01-09 2021-07-15 Disc Medicine, Inc. Methods of treating erythropoietic protoporphyria, x-linked protoporphyria, or congenital erythropoietic porphyria with glycine transport inhibitors
WO2022034146A1 (en) 2020-08-13 2022-02-17 Boehringer Ingelheim International Gmbh Treatment of cognitive impairement associated with schizophrenia
AU2021360172A1 (en) 2020-10-13 2023-03-30 Boehringer Ingelheim International Gmbh Process of reworking
WO2023097276A1 (en) * 2021-11-24 2023-06-01 Maplight Therapeutics, Inc. Methods of treating neurological disorders
CN114957087A (zh) * 2022-04-13 2022-08-30 湖南复瑞生物医药技术有限责任公司 一种帕罗韦德中间体制备方法
WO2023237103A1 (zh) * 2022-06-10 2023-12-14 成都百裕制药股份有限公司 吡咯烷衍生物、药物组合物及其在医药上的应用
WO2024042043A1 (en) 2022-08-24 2024-02-29 Boehringer Ingelheim International Gmbh A scalable process for the preparation of a glyt-1 inhibitor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1615634B1 (en) * 2003-04-10 2007-05-16 Ranbaxy Laboratories, Ltd. Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
AU2004281794B2 (en) 2003-10-14 2010-04-22 Pfizer Products Inc. Bicyclic [3.1.0] derivatives as glycine transporter inhibitors
DE102004035280A1 (de) 2004-07-21 2006-03-16 Robert Bosch Gmbh Kraftstoffinjektor mit direkter mehrstufiger Einspritzventilgliedansteuerung
JP2008526795A (ja) * 2005-01-06 2008-07-24 エフ.ホフマン−ラ ロシュ アーゲー 神経障害および神経精神疾患を処置するためのグリシントランスポータ1(glyt−1)阻害物質としての、スルファニル置換フェニルメタノン
EP1838308B1 (en) * 2005-01-07 2010-06-30 F. Hoffmann-Roche AG [4-(heteroaryl)piperazin-1-yl]-(2,5-substituted -phenyl)methanone derivatives as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
JP4647670B2 (ja) * 2005-02-07 2011-03-09 エフ.ホフマン−ラ ロシュ アーゲー グリシントランスポーター1の阻害剤としてのヘテロシクリル置換フェニルメタノン
EP2035371B1 (en) * 2006-06-22 2013-03-06 F. Hoffmann-La Roche AG Substituted phenyl methanone derivatives and their use as glyt1 and glyt2 receptor inhibitors
PL2041088T3 (pl) 2006-06-28 2014-07-31 Amgen Inc Inhibitory transportera-1 glicyny
CL2007003827A1 (es) * 2006-12-28 2008-09-26 Actelion Pharmaceuticals Ltd Compuestos derivados de n-(2-aza-biciclo(3.1.0)hex-3-ilmetil)amida; y su uso para prevenir o tratar la depresion, neurosis, esquizofrenia, ansiedad, adicciones, epilepsia, dolor, enfermedades cardiacas, entre otras.
UA105362C2 (en) 2008-04-02 2014-05-12 Бьорингер Ингельхайм Интернациональ Гмбх 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
US8497289B2 (en) * 2008-12-29 2013-07-30 Vanderbilt University 3.1.0 bicyclic GlyT1 inhibitors and methods of making and using same
PE20120500A1 (es) 2009-01-27 2012-05-04 Hoffmann La Roche Piperidinas sustituidas con heteroilamino y aroilamino como inhibidores de glyt-1

Also Published As

Publication number Publication date
MX2014001252A (es) 2014-05-13
PE20141352A1 (es) 2014-10-12
HRP20170695T1 (hr) 2017-07-28
ME02672B (me) 2017-06-20
UA114405C2 (uk) 2017-06-12
AR087436A1 (es) 2014-03-26
TW201321364A (zh) 2013-06-01
AP2014007399A0 (en) 2014-01-31
EA024933B1 (ru) 2016-11-30
IL229962A (en) 2016-09-29
CL2014000246A1 (es) 2014-08-08
US9012489B2 (en) 2015-04-21
JP2014524414A (ja) 2014-09-22
BR112014001642B1 (pt) 2022-03-22
DK2739615T3 (en) 2017-05-08
AU2012292036C1 (en) 2017-03-23
BR112014001642A2 (pt) 2017-02-14
AU2012292036B2 (en) 2016-10-06
EP2739615A1 (en) 2014-06-11
JP5850589B2 (ja) 2016-02-03
ES2623006T3 (es) 2017-07-10
CY1119326T1 (el) 2018-02-14
SI2739615T1 (sl) 2017-07-31
MX347828B (es) 2017-05-15
CN103797005A (zh) 2014-05-14
KR101944686B1 (ko) 2019-02-01
TN2014000044A1 (en) 2015-07-01
GEP20166483B (en) 2016-05-25
CN103797005B (zh) 2016-05-11
HK1193100A1 (zh) 2014-09-12
CA2843805A1 (en) 2013-02-07
WO2013017657A1 (en) 2013-02-07
MA35286B1 (fr) 2014-07-03
KR20140051922A (ko) 2014-05-02
RS55927B1 (sr) 2017-09-29
LT2739615T (lt) 2017-04-10
MY167396A (en) 2018-08-16
EP2739615B1 (en) 2017-03-15
AU2012292036A1 (en) 2014-01-16
CN105837562B (zh) 2020-01-17
ECSP14013221A (es) 2014-03-31
PT2739615T (pt) 2017-06-09
CA2843805C (en) 2021-03-23
TWI543974B (zh) 2016-08-01
CN105837562A (zh) 2016-08-10
PL2739615T3 (pl) 2017-08-31
UY34239A (es) 2013-02-28
EA201400183A1 (ru) 2014-06-30
HUE033134T2 (en) 2017-11-28
NZ619258A (en) 2015-12-24
US20130197011A1 (en) 2013-08-01

Similar Documents

Publication Publication Date Title
CO6870037A2 (es) Fenil-3-aza-biciclo[3,1,0]hex-3-il-metanonas y su uso como medicamento
CR20150380A (es) Compuestos de carbamoilpiridona policíclicos y su uso farmacéutico
CO6801774A2 (es) Compuestos de benzotiazol y su uso farmacéutico
BR112012021065A2 (pt) artigo de uso descartável
IL234628A0 (en) Imidazolyl-pyrimidines are converted into amino-indolyl and their use as drugs
BR112015006198A2 (pt) conjunto de cadeira
FR2968266B1 (fr) Trottinette triptyque pliante a roues escamotables
DK2585140T3 (da) Autoinjektor
BR112013008401A2 (pt) autoinjetor
BR112013008072A2 (pt) autoinjetor
DK2536452T3 (da) Autoinjektor
DK2585137T3 (da) Autoinjektor
CO6852094A2 (es) 3-alcoxi-, tioalquilo-y amino-4-amino-picolinatos 6-sustituidos y su uso como herbicidas
DK2654833T3 (da) Autoinjektor
BR302012005979S1 (pt) Configuração aplicada a cadeira
CO6990717A2 (es) Derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina
DK2654842T3 (da) Autoinjektor
BR112014017093A2 (pt) preparações contendo emodepside amorfo
CO6781486A2 (es) Compuestos y su uso
AR092882A1 (es) 1,2,4-triazin-3,5-dion-6-carboxamidas y su uso como herbicidas
EP2718283A4 (en) INDAZOLE AND PYRROLOPYRIDINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF
CO6781555A2 (es) Dimaleato de 9-[4-(3-cloro-2-fluoro-fenilamino)-7-metoxi-quinazolin-6-iloxi]-1,4-diaza-espiro[5.5]undecan-5-ona, su uso como medicamento y su preparación
CR20140362A (es) Fenilimidazopirazoles sustituidos y su uso
EP2837627A4 (en) AMIDOPYRIDINE DERIVATIVE AND USE THEREOF
BR112013015785A2 (pt) autoinjetor

Legal Events

Date Code Title Description
FG Application granted